Literature DB >> 10740167

Factors affecting survival for floor-of-mouth carcinoma.

D W Klotch1, C Muro-Cacho, T J Gal.   

Abstract

OBJECTIVES: The treatment of extensive floor-of-mouth carcinoma has remained a challenging problem for head and neck surgeons. We have reviewed our experience in the surgical management of floor-of-mouth cancer in an attempt to identify factors influencing survival.
METHODS: A total of 144 patients with cancer involving the floor of the mouth were treated between March 1988 and November 1995. A retrospective chart review was conducted that captured information including clinical staging, therapeutic modalities, pathologic findings, and patient follow-up. Factors affecting survival were assessed by nonparametric analysis and analysis of variance.
RESULTS: There was no statistical significance for the effects of vascular invasion (P = 0.4019), lymphatic invasion (P = 0.3430), bone invasion (P = 0.1548), or positive margins (P = 0.1113) on survival. Extranodal extension and recurrent disease were strongly suggestive of influencing survival but were not statistically significant (P = 0.0650 and P = 0.0504, respectively). Nodal disease significantly affected survival (P = 0.0138) but did not affect recurrence (P = 0.451).
CONCLUSION: Mean survival for this cohort was 30.6 months. Positive node status significantly affected mean overall survival in this series, whereas extracapsular disease did not. These data suggest that aggressive surgical management of neck disease is mandated to maximize survival.

Entities:  

Mesh:

Year:  2000        PMID: 10740167     DOI: 10.1067/mhn.2000.102185

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  How is neck dissection performed in Oral and Maxillofacial Surgery? Results of a representative nationwide survey among university and non-university hospitals in Germany.

Authors:  Andreas Pabst; Daniel G E Thiem; Elisabeth Goetze; Alexander K Bartella; Michael T Neuhaus; Jürgen Hoffmann; Alexander-N Zeller
Journal:  Clin Oral Investig       Date:  2021-03-29       Impact factor: 3.573

2.  Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.

Authors:  Lisa A Elferink; Vicente A Resto
Journal:  J Signal Transduct       Date:  2011-06-07

3.  Surgical margins and survival after head and neck cancer surgery.

Authors:  Reina Haque; Richard Contreras; Michael P McNicoll; Evelyn C Eckberg; Diana B Petitti
Journal:  BMC Ear Nose Throat Disord       Date:  2006-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.